Kalajzic, I., Staal, A., Yang, W., Wu, Y., Johnson, S.E., Feyen, J.H.M., Krueger, W., Maye, P., Yu, F., Zhao, Y., Kuo, L., Gupta, R.R., Achenie, L.E.K., Wang,H., Shin, D. and Rowe, D.W. 2005. Expression profile of osteoblast lineage at defined stages of differentiation. J Biol Chem (April 15 published online ahead of print). 

Yang W, Lu Y, Kalajzic I, Guo D, Harris MA, Gluhak-Heinrich J, Kotha S, Bonewald LF, Feng JQ, Rowe DW, Turner CH, Robling AG, Harris SE. 2005. Dentin matrix protein 1 gene cis-regulation: Use In osteocytes to characterize local responses to mechanical loading in vitro and In vivo. J Biol Chem (Feb 22 published online ahead of print).

Lukic, I.K., Grcevic, D., Kovacic, N., Katavic, V., Ivcevic, S., Kalajzic, I., Marusic, A. 2005. TNF-a receptor 1 Controls Endochondral Bone Formation in Adult Mice. Clinical and Experimental Immunology 139:236-244.

Yang, W., Kalajzic, I., Lu, Y., Guo, D., Harris, M.A., Gluhak-Heinrich, J., Bonewald, L.F., Feng, J.Q., Rowe, D.W., Harris, S.E. 2004. In vitro and In vivo study on osteocyte-specific mechanical signaling pathways. J Musculoskelet Neuron Interact. 4:386-387.

Katavic, V., Grcevic, D., Lukic, IK., Vucenik, V., Kovacic, N., Kalajzic, I. and Marusic, A. 2003. Non-functional Fas ligand increases the formation of cartilage early in the endochondral bone induction bby rhBMP-2. Life Sciences 74:13-28.

Kalajzic, I., Braut, A., Guo, D., Jiang, X., Kronenberg, M.S., Mina, M., Harris, S.E., Harris, S.E. and D.W. Rowe. Dentin matrix protein 1 expression during osteoblastic differentiation, generation of an osteocyte GFP-transgene. Bone 35:74-82.

Delany, A.M., Kalajzic, I. , Bradshaw, A.D., Sage, E.H. and Canalis, E. 2003. Osteonectin-null mutation compromises osteoblasts formation, maturation and survival. Endocrinology, 144(6):2588-2596

Rajan, T.V., Paciorkowski, N., Kalajzic, I. and McGuiness, I. 2003. Ascorbic acid is a requirement for the morphogenesis of the human filarial parasite Brugia malayi. J Parasit., 89 (4):868-870.

Kalajzic, I. , Kalajzic Z., Hurley, M.M., Lichtler A.C. and Rowe D.W. 2003. Stage specific inhibition of osteoblast lineage differentiation by FGF2 and noggin. J. Cell Biochem., 88: 1168-1176.

Kalajzic, Z., Liu, P., Kalajzic, I. , Du, Z., Braut, A., Mina, M., Canalis, E. and Rowe, D.W. 2002. Directing the expression of a GFP transgene in differentiated osteoblasts: Comparison between collagen and osteocalcin promoters. Bone, 31: 654-660.

Kalajzic, I. , Terzic, J., Rumboldt, Z., Mack, K., Naprta, A., Ledgard, F., Gronowicz, G., Clark, S.H. and Rowe, D.W. 2002. Osteoblastic Response to the Defective Matrix in the Osteogenesis Imperfecta Murine (OIM) Mouse. Endocrinology, 143: 1594-1601.

Braut, A., Kalajzic, I. , Kalajzic, Z., Rowe, D.W., Kollar, E.J. and Mina M. 2002. Col1a1-GFP transgene expression in developing incisors. Connect Tissue Res., 43: 216-9.

Kalajzic, I. , Kalajzic, Z., Kaliterna, M., Gronowicz, G., Clark, S.H., Lichtler, A.C. and Rowe, D.W. 2002. Use of type I collagen green fluorescent protein transgenes to identify subpopulations of cells at different stages of the osteoblast lineage. J. Bone Miner. Res., 17: 15-25.

Primorac D., Rowe D.W., Mottes M., Barisic I., Anticevic D., Mirandola S., Gomez LIra M., Kalajzic, I. , Kusec V. and Glorieux FH. 2001. Osteogenesis Imperfecta at the beginning of bone and joint decade. Croat. Med. J., 42: 392-414.

Visnjic, D., Kalajzic, I. , Gronowicz, G., Clark, S.H., Lichtler, A.C. and Rowe, D.W. 2001. Conditional ablation of the osteoblast lineage in Col2.3deltatk transgenic mice. J. Bone Miner. Res., 16: 2222-2232.

Liu, P. Kalajzic, I. , Stover ML., Rowe D.W, Lichtler A.C. 2001. Human bone marrow stromal cells are efficiently transduced by VSV pseudotyped retrovectors without affecting subsequent osteoblastic differentiation. Bone, 29: 331-335.

Dacic S., Kalajzic, I. , Visnjic D., Lichtler A.C., Rowe D.W. 2001. Col1a1-driven transgenic markers of osteoblast lineage progression. J. Bone Miner. Res., 16: 1228-1236.

Kalajzic, I. , Stover ML., Liu P., Kalajzic Z., Rowe D.W. and Lichtler A.C. 2001. Use of VSV-G pseudotyped retroviral vectors to target murine osteoprogenitor cells. Virology, 284: 37-45.

Stover ML., Wang CH.L., McKinstry M., Kalajzic, I. , Gronowicz G., Clark S.H., Rowe D.W. and Lichtler A.C. 2001. Bone directed expression of Col1a1 promoter driven self-inactivating retroviral vector in bone marrow cells and in transgenic mice. Mol. Ther., 3: 543-550.

Marusic A., Grcevic D., Katavic V., Kovacic N., Lukic I.K., Kalajzic, I. , Lorenzo J.A. 2000. Role of B-lymphocytes in new bone formation. Lab. Invest., 80: 1761-1774.